JL15003 injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JL15003 injection, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) [Phase 1, Phase 2]